AREG and prostate carcinoma: The oncogenic potential of AREG and its role in tissue invasion & metastasis, angiogenesis, resistance to apoptosis etc., has been reported in human epithelial malignancies, such as lung, breast, colorectal, ovary and prostate carcinomas, as well as, in some haematological and mesenchymal cancers [40–45].